These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9493321)
1. Pharmacokinetics, metabolism and pharmacodynamics of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey. Kakiki M; Ishihara H Xenobiotica; 1998 Jan; 28(1):77-91. PubMed ID: 9493321 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog. Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932 [TBL] [Abstract][Full Text] [Related]
3. Localization and disposition of a non-peptide angiotensin II type 1 receptor antagonist, and its glucuronide metabolite, in rat. Kakiki M; Tadano K Xenobiotica; 1997 Jul; 27(7):723-32. PubMed ID: 9253148 [TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962 [TBL] [Abstract][Full Text] [Related]
6. Localization of a novel non-peptide angiotensin II type 1 receptor antagonist, E4177, in rat adrenal glomerulosa. Kakiki M; Horie T Biol Pharm Bull; 1996 Oct; 19(10):1357-61. PubMed ID: 8913512 [TBL] [Abstract][Full Text] [Related]
7. Determination of angiotensin II receptor antagonist (E4177) in human plasma and urine by high-performance liquid chromatography. Seki T; Yamazaki K; Kayano M J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):101-6. PubMed ID: 9029319 [TBL] [Abstract][Full Text] [Related]
8. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man. Jezequel SG; Uden S; Wastall P Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043 [TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177. Okunishi H; Song K; Oka Y; Kobayashi T; Kawamoto T; Ishihara H; Mori N; Miyazaki M Jpn J Pharmacol; 1993 Jul; 62(3):239-44. PubMed ID: 8411773 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogs. Allen MC; Nocerini MR; Day WW Biopharm Drug Dispos; 1999 Oct; 20(7):319-26. PubMed ID: 10760839 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat. Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine. Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Walker DK; Ackland MJ; James GC; Muirhead GJ; Rance DJ; Wastall P; Wright PA Xenobiotica; 1999 Mar; 29(3):297-310. PubMed ID: 10219969 [TBL] [Abstract][Full Text] [Related]
14. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human. Timchalk C; Nolan RJ Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410 [TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys. Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
18. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys. Colletti AE; Krieter PA Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272 [TBL] [Abstract][Full Text] [Related]
19. Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite (BIA 5-961) in dog and monkey. Loureiro AI; Soares-da-Silva P Xenobiotica; 2015; 45(10):903-11. PubMed ID: 25869244 [TBL] [Abstract][Full Text] [Related]